First description of Streptococcus lutetiensis from a diseased cat.
Animals
Anti-Bacterial Agents
/ pharmacology
Cat Diseases
/ microbiology
Cats
Clindamycin
/ pharmacology
Diarrhea
/ microbiology
Disk Diffusion Antimicrobial Tests
/ veterinary
Drug Resistance, Multiple, Bacterial
Erythromycin
/ pharmacology
Feces
/ microbiology
Female
Fluoroquinolones
/ pharmacology
Intestinal Neoplasms
/ veterinary
Intestines
/ microbiology
Lymphoma
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
/ veterinary
Streptococcal Infections
/ microbiology
Streptococcus
/ classification
Tetracycline
/ pharmacology
Streptococcus lutetiensis
antimicrobial resistance
cat
identification
intestinal disorders
Journal
Letters in applied microbiology
ISSN: 1472-765X
Titre abrégé: Lett Appl Microbiol
Pays: England
ID NLM: 8510094
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
29
01
2019
revised:
11
04
2019
accepted:
23
04
2019
pubmed:
8
5
2019
medline:
8
10
2019
entrez:
8
5
2019
Statut:
ppublish
Résumé
This paper describes for the first time the isolation of Streptococcus lutetiensis in a cat with intestinal lymphoma. The Streptococcus bovis group has undergone significant taxonomic changes over the past two decades and, in 2002, Poyart et al. described two distinct novel species within the genus Streptococcus: Streptococcus lutetiensis and Streptococcus pasteurianus. The bovis group streptococci include commensal species and subspecies or opportunistic pathogens of humans and animals. The cat was referred to the Veterinary Teaching Hospital, University of Bologna for chronic diarrhoea associated with fresh blood. A diagnosis of intestinal lymphoma was advanced. S. lutetiensis was accidentally isolated from the faeces of the cat and identified through MALDI-TOF and 16s rRNA sequencing. The Kirby-Bauer test revealed that the isolate was resistant to enrofloxacin, erythromycin, clindamycin, marbofloxacin and tetracycline. The detection of S. lutetiensis in cat faeces might suggest that it could be a normal inhabitant of cat intestinal tract or that it could be involved in the manifestation of intestinal diseases. Since bacteria belonging to the S. bovis group are considered emerging pathogens, additional research is required to evaluate the role of S. lutetiensis in cats and its role in the transmission of antimicrobial resistance. SIGNIFICANCE AND IMPACT OF THE STUDY: In this study the isolation of Streptococcus lutetiensis from a cat with intestinal lymphoma was described for the first time. An antimicrobial susceptibility test performed by means of the disc diffusion method revealed that the isolate was resistant to enrofloxacin, erythromycin, clindamycin, marbofloxacin and tetracycline. Nowadays the ecological or pathogenetic role of S. lutetiensis in the gut of animals remains unclear but, even if its role as commensal bacterium was confirmed, the presence of multi-resistant S. lutetiensis in cat gut could favour the transmission of antimicrobial resistance to other bacteria.
Substances chimiques
Anti-Bacterial Agents
0
Fluoroquinolones
0
Clindamycin
3U02EL437C
Erythromycin
63937KV33D
marbofloxacin
8X09WU898T
Tetracycline
F8VB5M810T
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
96-99Informations de copyright
© 2019 The Society for Applied Microbiology.